COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,757 Articles (22,943 medRxiv, 8,814 bioRxiv)

Most recent first Previous |  Page 1926: Articles 19251-19260  | Next

Problems with Evidence Assessment in COVID-19 Health Policy Impact Evaluation (PEACHPIE): A systematic strength of methods review
Haber, N. A., Clarke-Deelder, E., Feller, A., Smith, E. R., Salomon, J., MacCormack-Gelles, B., Stone, E. M., Bolster-Foucault, C., Daw, J. R., Hatfield, L. A., Fry, C. E., Boyer, C. B., Ben-Michael, E., Joyce, C. M., Linas, B. S., Schmid, I., Au, E. H., Wieten, S. E., Jarrett, B. A., Axfors, C., Nguyen, V. T., Griffin, B. A., Bilinski, A., Stuart, E. A.
10.1101/2021.01.21.21250243 — Posted: 2021-01-22 Discussion: Onsite
Potential contribution of climate conditions on COVID-19 pandemic transmission over West and North African countries
Diouf, I., Sy, S., Senghor, H., Fall, P., Diouf, D., Diakhate, M., Thiaw, W. M., Gaye, A. T.
10.1101/2021.01.21.21250231 — Posted: 2021-01-22
Excess mortality associated with the COVID-19 pandemic among Californians 18-65 years of age, by occupational sector and occupation: March through October 2020
Chen, Y.-H., Glymour, M., Riley, A., Balmes, J., Duchowny, K., Harrison, R., Matthay, E., Bibbins-Domingo, K.
10.1101/2021.01.21.21250266 — Posted: 2021-01-22 Discussion: Onsite | Offsite
Simulating the impact of different vaccination policies on the COVID-19 pandemic in New York City
Yang, W., Kandula, S., Shaman, J.
10.1101/2021.01.21.21250228 — Posted: 2021-01-22 Discussion: Onsite
A cross-sectional analysis of demographic and behavioral risk factors of SARS-CoV-2 antibody positivity among a sample of U.S. college students
Kianersi, S., Ludema, C., Macy, J. T., Garcia, E., Chen, C., Luetke, M., Lown, M. H., Rosenberg, M.
10.1101/2021.01.20.21249905 — Posted: 2021-01-22 Discussion: Offsite
Longitudinal trends and risk factors for depressed mood among Canadian adults during the first wave of COVID-19
Betini, G., Hirdes, J., Adekpedjou, R., Perlman, C., Huculak, N., Hebert, P.
10.1101/2021.01.21.20245795 — Posted: 2021-01-22
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis
Abeldano Zuniga, R. A., Gonzalez Villoria, R. A. M., Elizondo, M. V., Nicolas Osorio, A. Y., Coca, S. M.
10.1101/2021.01.16.21249956 — Posted: 2021-01-22
Clinical prediction rule for SARS-CoV-2 infection from 116 U.S. emergency departments
Kline, J., RECOVER Network
10.1101/2021.01.20.21249656 — Posted: 2021-01-22
Redeployment and training of healthcare professionals to Intensive Care during COVID-19: a systemic review
Vera San Juan, N., Camilleri, M., Jeans, J. P., Monkhouse, A., Chisnall, G., Vindrola-Padros, C.
10.1101/2021.01.21.21250230 — Posted: 2021-01-22
REACT-1 round 8 interim report: SARS-CoV-2 prevalence during the initial stages of the third national lockdown in England
Riley, S., Ainslie, K. E. C., Eales, O., Walters, C. E., Wang, H., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2021.01.20.21250158 — Posted: 2021-01-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).